Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197704 · ClinicalTrials.gov registry record · Phase 3
Nutrition, Immunology and Epidemiology of Tuberculosis
A Phase 3 study of Tuberculosis, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 876
- Enrollment target
- 1
- Study location
NCT00197704 is a Phase 3 study of Tuberculosis that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 876 participants, roughly in line with the 904-participant average among 29 other Tuberculosis trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00197704, a Phase 3 study of Tuberculosis, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 876 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Multivitamins
Study Locations (1)
Massachusetts
- Harvard School of Public Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 876 participants |
| Start Date | 2000-03 |
| Est. Completion | 2004-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00197704
The ClinicalTrials.gov registry entry for NCT00197704 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 876 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 904-participant average among 29 other Tuberculosis trials with a reported enrollment target. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00197704 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00197704 about?
NCT00197704 is a clinical study titled "Nutrition, Immunology and Epidemiology of Tuberculosis". The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1
What is the current status of trial NCT00197704?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 876 participants. The study started on 2000-03. Estimated completion is 2004-05.
What conditions does trial NCT00197704 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT00197704?
The interventions under investigation include: Placebo (OTHER), Multivitamins (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197704?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00197704 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.